Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker VIR
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 2,407 | $26.7K | 10b5-1 | Nov 3, 2026 | Form 4 ↗ 1 day later · 3,750 shares | Form 144 ↗ |
| Nov 2, 2026 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 1,343 | $15.2K | — | Nov 2, 2026 | Form 4 ↗ 2 days later · 3,750 shares | Form 144 ↗ |
| Sep 17, 2026 | Jason O'Byrne Former Officer | VIR Vir Biotechnology, Inc. | 19,357 | $212.9K | — | Sep 17, 2026 | — | Form 144 ↗ |
| Sep 9, 2026 | Jason O'Byrne Former Officer | VIR Vir Biotechnology, Inc. | 28,333 | $315.2K | — | Sep 9, 2026 | — | Form 144 ↗ |
| Aug 25, 2026 | Jason O'Byrne Former Officer | VIR Vir Biotechnology, Inc. | 23,148 | $242.6K | — | Aug 25, 2026 | — | Form 144 ↗ |
| Aug 24, 2026 | Jason O'Byrne Former Officer | VIR Vir Biotechnology, Inc. | 14,352 | $142.1K | — | Aug 24, 2026 | — | Form 144 ↗ |
| Aug 21, 2026 | Jason O'Byrne Former Officer | VIR Vir Biotechnology, Inc. | 25,000 | $245.3K | — | Aug 21, 2026 | — | Form 144 ↗ |
| Jun 29, 2026 | Ramasastry Saira Former Director | VIR Vir Biotechnology, Inc. | 16,000 | $165.1K | — | Jun 29, 2026 | — | Form 144 ↗ |
| Jun 1, 2026 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 379 | $3,582 | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 379 shares | Form 144 ↗ |
| Jun 1, 2026 | Janet Napolitano Director | VIR Vir Biotechnology, Inc. | 3,200 | $30.2K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 3,200 shares | Form 144 ↗ |
| Apr 30, 2026 | Mark Eisner Former Officer | VIR Vir Biotechnology, Inc. | 88,958 | $916.3K | — | Apr 30, 2026 | — | Form 144 ↗ |
| Apr 6, 2026 | Marianne De Backer Officer, Director | VIR Vir Biotechnology, Inc. | 72,559 | $664.3K | — | Apr 6, 2026 | Form 4 ↗ 1 day later · 72,559 shares | Form 144 ↗ |
| Mar 23, 2026 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 7,711 | $70.3K | 10b5-1 | Mar 23, 2026 | Form 4 ↗ 1 day later · 7,711 shares | Form 144 ↗ |
| Mar 2, 2026 | Vicki Lee Sato Director | VIR Vir Biotechnology, Inc. | 88,000 | $799.9K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 1 day later · 22,000 shares | Form 144 ↗ |
| Feb 25, 2026 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 13,700 | $134.5K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 16,817 shares | Form 144 ↗ |
| Feb 25, 2026 | Mark Eisner Officer | VIR Vir Biotechnology, Inc. | 1,889 | $18.5K | 10b5-1 | Feb 25, 2026 | Form 4 ↗ 1 day later · 3,505 shares | Form 144 ↗ |
| Feb 25, 2026 | SVF Endurance (Cayman) Limited Stockholder | VIR Vir Biotechnology, Inc. | 400,000 | $3.8M | — | Feb 25, 2026 | — | Form 144 ↗ |
| Feb 24, 2026 | Mark Eisner Officer | VIR Vir Biotechnology, Inc. | 1,616 | $15.4K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 3,505 shares | Form 144 ↗ |
| Feb 24, 2026 | Marianne De Backer Officer, Director | VIR Vir Biotechnology, Inc. | 14,762 | $140.7K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 14,762 shares | Form 144 ↗ |
| Feb 24, 2026 | Jason O'Byrne Officer | VIR Vir Biotechnology, Inc. | 1,634 | $15.6K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 1,634 shares | Form 144 ↗ |
| Feb 24, 2026 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 1,430 | $13.6K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 1,430 shares | Form 144 ↗ |
| Feb 24, 2026 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 3,117 | $29.7K | — | Feb 24, 2026 | Form 4 ↗ 2 days later · 16,817 shares | Form 144 ↗ |
| Feb 24, 2026 | Vicki Lee Sato Director | VIR Vir Biotechnology, Inc. | 20,377 | $151.4K | 10b5-1 | Feb 24, 2026 | Form 4 ↗ 2 days later · 42,377 shares | Form 144 ↗ |
| Feb 23, 2026 | Jason O'Byrne Officer | VIR Vir Biotechnology, Inc. | 2,089 | $15.6K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 2,089 shares | Form 144 ↗ |
| Feb 23, 2026 | Mark Eisner Officer | VIR Vir Biotechnology, Inc. | 2,089 | $15.6K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 2,089 shares | Form 144 ↗ |
| Feb 23, 2026 | Marianne De Backer Officer, Director | VIR Vir Biotechnology, Inc. | 19,039 | $141.9K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 19,039 shares | Form 144 ↗ |
| Feb 23, 2026 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 4,445 | $33.1K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 4,445 shares | Form 144 ↗ |
| Feb 23, 2026 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 1,829 | $13.6K | — | Feb 23, 2026 | Form 4 ↗ 1 day later · 1,829 shares | Form 144 ↗ |
| Feb 13, 2026 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 1,530 | $11.9K | — | Feb 13, 2026 | Form 4 ↗ 5 days later · 1,530 shares | Form 144 ↗ |
| Jan 14, 2026 | SVF Endurance (Cayman) Limited Stockholder | VIR Vir Biotechnology, Inc. | 1.25M | $8.5M | 10b5-1 | Jan 14, 2026 | — | Form 144 ↗ |
| Jan 2, 2026 | Vicki Lee Sato Director | VIR Vir Biotechnology, Inc. | 66,000 | $398.0K | 10b5-1 | Jan 2, 2026 | Form 4 ↗ 3 days later · 22,000 shares | Form 144 ↗ |
| Nov 25, 2025 | SVF Endurance (Cayman) Limited 10% Stockholder | VIR Vir Biotechnology, Inc. | 1.25M | $8.1M | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 1 day later · 463,774 shares | Form 144 ↗ |
| Nov 17, 2025 | Jason O'Byrne Officer | VIR Vir Biotechnology, Inc. | 6,799 | $37.8K | — | Nov 17, 2025 | Form 4 ↗ 1 day later · 6,799 shares | Form 144 ↗ |
| Nov 5, 2025 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 2,385 | $12.3K | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 2 days later · 2,385 shares | Form 144 ↗ |
| Nov 3, 2025 | de Verneuil Vanina Officer | VIR Vir Biotechnology, Inc. | 1,365 | $8,003 | — | Nov 3, 2025 | Form 4 ↗ 1 day later · 1,365 shares | Form 144 ↗ |
| Oct 21, 2025 | SVF Endurance (Cayman) Limited 10% Stockholder | VIR Vir Biotechnology, Inc. | 834,202 | $5.2M | 10b5-1 | Oct 21, 2025 | Form 4 ↗ 1 day later · 330,210 shares | Form 144 ↗ |
| Oct 3, 2025 | SVF Endurance (Cayman) Limited 10% Stockholder | VIR Vir Biotechnology, Inc. | 1.67M | $9.5M | 10b5-1 | Oct 3, 2025 | Form 4 ↗ 4 days later · 524,297 shares | Form 144 ↗ |
| Oct 1, 2025 | Vicki Lee Sato Director | VIR Vir Biotechnology, Inc. | 66,000 | $376.9K | 10b5-1 | Oct 1, 2025 | Form 4 ↗ 1 day later · 22,000 shares | Form 144 ↗ |
| Jul 17, 2025 | Mark Eisner Officer | VIR Vir Biotechnology, Inc. | 3,586 | $19.4K | 10b5-1 | Jul 17, 2025 | Form 4 ↗ same day · 10,382 shares | Form 144 ↗ |
| Jul 15, 2025 | Mark Eisner Officer | VIR Vir Biotechnology, Inc. | 6,796 | $37.2K | — | Jul 15, 2025 | Form 4 ↗ 2 days later · 10,382 shares | Form 144 ↗ |
| Jul 1, 2025 | Vicki Lee Sato Director | VIR Vir Biotechnology, Inc. | 66,000 | $332.6K | 10b5-1 | Jul 1, 2025 | Form 4 ↗ 1 day later · 22,000 shares | Form 144 ↗ |
| Jun 11, 2025 | George Scangos Former Director | VIR Vir Biotechnology, Inc. | 19,957 | $108.0K | — | Jun 11, 2025 | — | Form 144 ↗ |
| Jun 10, 2025 | George Scangos Former Director | VIR Vir Biotechnology, Inc. | 50,000 | $273.9K | — | Jun 10, 2025 | — | Form 144 ↗ |
| Jun 9, 2025 | George Scangos Former Director | VIR Vir Biotechnology, Inc. | 50,000 | $270.6K | — | Jun 9, 2025 | — | Form 144 ↗ |
| Jun 2, 2025 | Janet Ann Napolitano Director | VIR Vir Biotechnology, Inc. | 3,200 | $15.8K | 10b5-1 | Jun 2, 2025 | Form 4 ↗ same day · 3,200 shares | Form 144 ↗ |
| Apr 3, 2025 | Marianne De Backer Officer and Director | VIR Vir Biotechnology, Inc. | 79,712 | $474.2K | — | Apr 3, 2025 | Form 4 ↗ 1 day later · 79,712 shares | Form 144 ↗ |
| Feb 26, 2025 | Vanina de Verneuil Officer | VIR Vir Biotechnology, Inc. | 7,373 | $67.1K | 10b5-1 | Feb 26, 2025 | Form 4 ↗ 1 day later · 7,373 shares | Form 144 ↗ |
| Feb 24, 2025 | George Scangos Director | VIR Vir Biotechnology, Inc. | 10,056 | $95.1K | 10b5-1 | Feb 24, 2025 | Form 4 ↗ 1 day later · 10,056 shares | Form 144 ↗ |
| Feb 24, 2025 | Brent Sabatini Officer | VIR Vir Biotechnology, Inc. | 1,562 | $14.8K | 10b5-1 | Feb 24, 2025 | Form 4 ↗ 1 day later · 1,562 shares | Form 144 ↗ |
| Feb 24, 2025 | Ann Hanly Officer | VIR Vir Biotechnology, Inc. | 14,168 | $133.9K | 10b5-1 | Feb 24, 2025 | Form 4 ↗ 1 day later · 14,168 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 9:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances